Stock Price
10,170.00
Daily Change
85.00 0.84%
Monthly
8.84%
Yearly
36.04%
Q1 Forecast
10,017.80



Peers Price Chg Day Year Date
M3 1,614.00 -1.00 -0.06% -9.53% Mar/05
Kyowa Hakko Kirin 2,164.00 -67.00 -3.00% -0.12% Mar/05
Takeda 5,631.00 23.00 0.41% 25.58% Mar/05
Astellas Pharma 2,384.50 53.00 2.27% 61.99% Mar/05
Sumitomo Dainippon 1,845.00 -42.50 -2.25% 165.09% Mar/05
Shionogi 3,440.00 22.00 0.64% 48.63% Mar/05
Chugai Pharma 9,727.00 -30.00 -0.31% 32.30% Mar/05
Eisai 4,895.00 89.00 1.85% 13.63% Mar/05
Terumo 1,975.50 33.50 1.73% -29.28% Mar/05
Daiichi Sankyo 2,844.00 34.00 1.21% -19.77% Mar/05

Indexes Price Day Year Date
JP225 55705 1,032.52 1.90% 47.74% Mar/05

Otsuka Holdings traded at 10,170.00 this Thursday March 5th, increasing 85.00 or 0.84 percent since the previous trading session. Looking back, over the last four weeks, Otsuka Holdings gained 8.84 percent. Over the last 12 months, its price rose by 36.04 percent. Looking ahead, we forecast Otsuka Holdings to be priced at 10,017.80 by the end of this quarter and at 8,838.20 in one year, according to Trading Economics global macro models projections and analysts expectations.

Otsuka Holdings Co., Ltd. is a Japan-based company mainly engaged in the medical and nutraceuticals related business and other businesses. The Company operates through four business segments. The Medical-related segment is engaged in the sale of ethical drugs, and the research development and export of therapeutic drugs. The Nutraceuticals-related segment is engaged in the manufacture, purchase and sale of nutraceuticals-related products, such as functional food and dietary supplements. The Consumer-related segment is engaged in the manufacture and sale of consumer products and mineral water. The Others segment is engaged in the manufacture and sale of chemical products, the manufacture, sale and import of measuring equipment, and the manufacture of synthetic resin molding products.